Back to all MindMaze Therapeutics Holding SA press releases
MindMaze Therapeutics Holding SA
- OTCQB:MMTZF
- SIX:MMTX
MindMaze Therapeutics Reports H1 2026 Revenue of CHF 0.5 Million and Corporate Update
Published
At a glance
- Company
- MindMaze Therapeutics Holding SA
- Listings
- OTCQB:MMTZF, SIX:MMTX
- Announcement type
- Financial results
- Published
- Reporting period
- H1 2026
- Source announcement
- eqs-news.com
| Measure | Figure | Period |
|---|---|---|
| Revenue | CHF 0.5 million | H1 2026 |
| Net loss | CHF 6.9 million | H1 2026 |
Figures are quoted from this announcement and selected automatically.
FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices
Announcement Summary
On August 27, 2026, MindMaze Therapeutics Holding SA (SIX: MMTX) announced its 2026 half-year report and a corporate update.
- The report includes interim financial statements for the six months ended June 30, 2026, and is available on the Company’s website.
- The report states H1 2026 revenue of CHF 0.5 million and a net loss of CHF 6.9 million.
- CHF 4.0 million was received under a CHF 8.0 million equity financing agreement; the remaining investment is scheduled for the second half of 2026.
- The Company expanded U.S. commercial capabilities, developed its customer pipeline, and entered a channel partnership with Vibra Healthcare.
The update covered SwissNeuroRehab enrollment, REACT-AVC’s French launch, University of Pittsburgh stroke research, and disposal of non-neurology legacy operations.
Investor FAQs
Source announcement
- Company
- MindMaze Therapeutics Holding SA
- Title
- MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
- Published
- Source site
- eqs-news.com
Read the source announcement on eqs-news.com
FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.
Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.
Read the original press release
Full text as published, unedited.